Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -14.52% is 6632% below its 5-year average of -0.22%, near the high end of its 5-year range (-1830.73%–27.72%).
10.83% below its 12-month average of -13.10%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -36.44%.
NET PROFIT MARGIN
-14.52%
NET PROFIT MARGIN AVG TTM
-13.10%
NET PROFIT MARGIN AVG 3Y
8.59%
NET PROFIT MARGIN AVG 5Y
-0.22%
NET PROFIT MARGIN AVG 10Y
-467.89%
NET PROFIT MARGIN AVG 15Y
-671.96%
NET PROFIT MARGIN AVG 20Y
-360.34%
CURRENT VS TTM AVG
-10.83%
CURRENT VS 3Y AVG
-269.02%
CURRENT VS 5Y AVG
-6632.03%
CURRENT VS 10Y AVG
+96.90%
CURRENT VS 15Y AVG
+97.84%
CURRENT VS 20Y AVG
+95.97%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 629 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Gyre Therapeutics, Inc.
Market Cap
$785.44M
Net Profit Margin
-14.52%
TTM Avg
-13.10%
3Y Avg
8.59%
5Y Avg
-0.22%
Market Cap
$785.71M
Net Profit Margin
-7.58%
TTM Avg
0.29%
3Y Avg
-4.57%
5Y Avg
-4.54%
Market Cap
$770.68M
Net Profit Margin
-147.38%
TTM Avg
-372.93%
3Y Avg
-22199.44%
5Y Avg
-19748.48%
Market Cap
$769.83M
Net Profit Margin
-34.17%
TTM Avg
-136.69%
3Y Avg
-25443.25%
5Y Avg
-23332.75%
Market Cap
$768.31M
Net Profit Margin
1.92%
TTM Avg
0.94%
3Y Avg
-28.83%
5Y Avg
-18.64%
Market Cap
$805.59M
Net Profit Margin
20.69%
TTM Avg
35.62%
3Y Avg
36.75%
5Y Avg
38.26%
Market Cap
$760.77M
Net Profit Margin
-4490.89%
TTM Avg
-2245.45%
3Y Avg
-2245.45%
5Y Avg
-2245.45%
Market Cap
$813.96M
Net Profit Margin
-12.35%
TTM Avg
-13.43%
3Y Avg
-52.20%
5Y Avg
-503.49%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gyre Therapeutics, Inc. (GYRE) | $785.44M | -14.52% | -13.10% | 8.59% | -0.22% |
| AdaptHealth Corp. (AHCO)vs › | $785.71M | -7.58% | 0.29% | -4.57% | -4.54% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $770.68M | -147.38% | -372.93% | -22199.44% | -19748.48% |
| Geron Corporation (GERN)vs › | $769.83M | -34.17% | -136.69% | -25443.25% | -23332.75% |
| Mesa Laboratories, Inc. (MLAB)vs › | $768.31M | 1.92% | 0.94% | -28.83% | -18.64% |
| InMode Ltd. (INMD)vs › | $805.59M | 20.69% | 35.62% | 36.75% | 38.26% |
| Apnimed, Inc. (APMD)vs › | $805.62M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $760.77M | -4490.89% | -2245.45% | -2245.45% | -2245.45% |
| Ardelyx, Inc. (ARDX)vs › | $813.96M | -12.35% | -13.43% | -52.20% | -503.49% |
| Candel Therapeutics, Inc. (CADL)vs › | $753.58M | 0.00% | 0.00% | -3758.80% | -9679.73% |
Operating Margin
9.9%
Net Profit Margin
-14.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -36.44% |
| 2026-03-31 | -38.26% |
| 2025-12-31 | -4.63% |
| 2025-09-30 | 11.81% |
| 2025-06-30 | 2.01% |
| 2025-03-31 | 12.23% |
| 2024-12-31 | -0.36% |
| 2024-09-30 | 4.41% |
| 2024-06-30 | 13.99% |
| 2024-03-31 | 27.72% |
| 2023-12-31 | -372.06% |
| 2023-09-30 | 12.41% |
| 2023-06-30 | 6.32% |
| 2023-03-31 | 9.00% |
| 2022-12-31 | -12.22% |
| 2022-09-30 | -11.44% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -1830.73% |
| 2021-12-31 | -833.16% |
| 2021-09-30 | -1097.78% |
| 2021-06-30 | -1760.42% |
| 2021-03-31 | -1529.52% |
| 2020-12-31 | -930.92% |
| 2020-09-30 | -1795.41% |
| 2020-06-30 | -1040.29% |
| 2020-03-31 | -24.76% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 180616.67% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | -84033.33% |
| 2017-12-31 | -1809.12% |
| 2017-09-30 | -1821.70% |
| 2017-06-30 | -5294.59% |
| 2017-03-31 | -1526.94% |
| 2016-12-31 | -5281.69% |
| 2016-09-30 | -4377.06% |
| 2016-06-30 | -4433.94% |
| 2016-03-31 | -3295.41% |
| 2015-12-31 | -4706.42% |
| 2015-09-30 | -4633.94% |
| 2015-06-30 | -504.77% |
| 2015-03-31 | -1003.27% |
| 2014-12-31 | -277.96% |
| 2014-09-30 | -19440.00% |
| 2014-06-30 | -22600.00% |
| 2014-03-31 | -17240.23% |
| 2013-12-31 | -14372.04% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | -228.11% |
| 2012-12-31 | -2689.83% |
| 2012-09-30 | -1025.91% |
| 2012-06-30 | 43.07% |
| 2012-03-31 | 9.88% |
| 2011-12-31 | -51.76% |
| 2011-09-30 | -47.77% |
| 2011-06-30 | -10.88% |
| 2011-03-31 | 32.28% |
| 2010-12-31 | -9.21% |
| 2010-09-30 | 11.40% |
| 2010-06-30 | 18.09% |
| 2010-03-31 | 34.81% |
| 2009-12-31 | -770.33% |
| 2009-09-30 | 10.53% |
| 2009-06-30 | -341.10% |
| 2009-03-31 | -76.16% |
| 2008-12-31 | -83.29% |
| 2008-09-30 | 0.08% |
| 2008-06-30 | 0.08% |
| 2008-03-31 | 0.06% |
| 2007-12-31 | -215.01% |
| 2007-09-30 | -0.24% |
| 2007-06-30 | -0.29% |
| 2007-03-31 | -233.69% |
| 2006-12-31 | 66.36% |
| 2006-09-30 | -0.49% |
| 2006-06-30 | -783.30% |
| 2006-03-31 | -0.86% |
| 2005-12-31 | -2734.52% |
| 2005-09-30 | -2045.52% |
| 2005-06-30 | -2705.02% |
| 2005-03-31 | -2452.82% |
